Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/56005

Título:

American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients

Otros títulos:

Coordinador:

Director:

Compilador:

Autor:

Gómez-Mesa, Juan Esteban
Gutiérrez-Posso, Juliana María
Escalante-Forero, Manuela
Ormaechea-Gorricho, Gabriela

Tutor:

Tipo de documento:

Artículo

Editor:

Palabras clave:

Ambulatory
Heart failure
Hospitable
America

Descriptores:

ANTAGONISTAS ADRENÉRGICOS BETA
USOS TERAPÉUTICOS
ANCIANO
PERSONA DE MEDIANA EDAD
ANTAGONISTAS DE RECEPTORES DE ANGIOTENSINA
INHIBIDORES DE LA ENZIMA CONVERTIDORA DE ANGIOTENSINA
HUMANOS
INSUFICIENCIA CARDÍACA
DIAGNÓSTICO
ADMINISTRACIÓN DEL TRATAMIENTO FARMACOLÓGICO
EPIDEMIOLOGÍA
ESTUDIOS PROSPECTIVOS
ANTAGONISTAS DE RECEPTORES DE MINERALOCORTICOIDES
SISTEMA DE REGISTROS
VOLUMEN SISTÓLICO

Año de publicación:

2024

Contenido:

Resumen:

Background: About 80% of cardiovascular diseases (including heart failure [HF]) occur in low-income and developing countries. However, most clinical trials are conducted in developed countries. Hypothesis: The American Registry of Ambulatory or Acutely Decompensated Heart Failure (AMERICCAASS) aims to describe the sociodemographic characteristics of HF, comorbidities, clinical presentation, and pharmacological management of patients with ambulatory or acutely decompensated HF in America. Methodology: Descriptive, observational, prospective, and multicenter registry, which includes patients >18 years with HF in an outpatient or hospital setting. Collected information is stored in the REDCap electronic platform. Quantitative variables are defined according to the normality of the variable using the Shapiro-Wilk test. Results: This analysis includes data from the first 1000 patients recruited. 63.5% were men, the median age of 66 years (interquartile range 56.7-75.4), and 77.6% of the patients were older than 55 years old. The percentage of use of the four pharmacological pillars at the time of recruitment was 70.7% for beta-blockers (BB), 77.4% for angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB II)/angiotensin receptor-neprilysin inhibitor (ARNI), 56.8% for mineralocorticoid receptor antagonists (MRA), and 30.7% for sodium-glucose cotransporter type-2 inhibitors (SGLT2i). The main cause of decompensation in hospitalized patients was HF progression (64.4%), and the predominant hemodynamic profile was wet-warm (68.3%). Conclusions: AMERICCAASS is the first continental registry to include hospitalized or outpatient patients with HF. Regarding optimal medical therapy, approximately a quarter of the patients still need to receive BB and ACEI/ARB/ARNI, less than half do not receive MRA, and more than two-thirds do not receive SGLT2i.

Descripción:

Juan Esteban Gómez-Mesa 1 2 3, Juliana María Gutiérrez-Posso 3, Manuela Escalante-Forero 3, Brayan Daniel Córdoba-Melo 3, Paula Andrea Cárdenas-Marín 1 2, Eduardo R Perna 4, Mádelyn Raquel Valle-Ramos 5, Germán Camilo Giraldo-González 6, Noel Alberto Flórez-Alarcón 2, Ida Fabiola Rodríguez-Caballero 7, Cristian Núñez-Carrizo 8 9, Luz Teresa Cabral-Gueyraud 10, Sarah Raquel Marte-Arias 11, Elizabeth Ashley Hardin 12, Amada Álvarez-Sangabriel 13, María Eugenia Menjívar-De Ramos 14, Kwame van der Hilst 15 16, Licurgo Jacob Cruz-Díaz 17, Sergio Roberto Fausto Ovando 18, Luis Arturo Rodríguez 19, Juan Pablo Escalante 20, Gabriela Ormaechea-Gorricho 21, Norberto Raul Bornancini 22, María Juliana Rodríguez-González 23, Sebastián Campbell-Quintero 24, Raquel E González-Hormostay 25 26 27, Guillermo Oviedo-Pereira 28, Guillermo Trout-Guardiola 29, Juan Justiniano Encina 30, Ana Margarita Jerez-Castro 31, Mark Drazner 32, Daniel Quesada-Chaves 33, Alexander Romero-Guerra 34, Víctor Alejandro Rossel-Mariángel 35 36, Mario Speranza 37
Affiliations 1Department of Cardiology, Fundación Valle del Lili, Cali, Colombia. 2Department of Health Sciences, Universidad Icesi, Cali, Colombia. 3Fundación Valle del Lili, Centro de investigaciones Clínicas, Cali, Colombia. 4Instituto De Cardiología J. F. Cabral, Department of Heart Failure and Pulmonary Hypertension, Corrientes, Argentina. 5Department of Internal Medicine, Hospital Regional de Zacapa, Ciudad de Zacapa, Guatemala. 6Department of Cardiology, Todo por el Corazón cardiology center, Manizales, Colombia. 7Instituto Nacional de Cardiología "Prof. Dr. Juan Adolfo Cattonni", Asunción, Paraguay. 8Clínica El Castaño, Multipurpose Unit, Echocardiography and Ambulatory, San Juan, Argentina. 9CIMAC, Multipurpose Unit, Echocardiography and Ambulatory, San Juan, Argentina. 10Hospital Nacional de Itaugua, Department of Cardiology, Itaugua, Paraguay. 11Department of Cardiology, Clínica Universitaria Unión Médica del Norte, Santiago, Dominican Republic. 12Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 13Emergency Department and Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico city, Mexico. 14Department of Cardiology, Centro de Cardiología y Ortopedia (CCO), San Salvador, El Salvador. 15Department of Cardiology, Thorax Center Paramaribo, Paramaribo, Suriname. 16Department of Cardiology, Academic Hospital Paramaribo, Paramaribo, Suriname. 17Department of Cardiology, Hospital Regional Universitario "Presidente Estrella Ureña", Santiago, Dominican Republic. 18Department of Cardiology, Cardiocentro Chimaltenango, Chimaltenango, Guatemala. 19Cardiology Unit, Hospital Roosevelt, Guatemala city, Guatemala. 20Instituto Cardiovascular de Rosario, Heart Failure, Transplantation and Pulmonary Hypertension Unit, Rosario, Argentina. 21Department of Internal Medicine, Hospital de Clínicas "Dr. Manuel Quintela", Montevideo, Uruguay. 22Department of Cardiology, Centro Médico Talar, Buenos Aires, Argentina. 23Department of Heart Failure and Transplantation, LaCardio, Bogota, Colombia. 24Department of Cardiology, Clínica Medilaser, Florencia, Colombia. 25ASCARDIO, Heart Failure Unit, Barquisimeto, Venezuela. 26ASCARDIO, Coronary Intensive Care Unit, Barquisimeto, Venezuela. 27ASCARDIO, Echocardiography Laboratory, Barquisimeto, Venezuela. 28Department of Internal Medicine, Instituto De Previsión Social, Asuncion, Paraguay. 29Department of Cardiology, GrupSalud, Santa Marta, Colombia. 30Hospital Universitario Japonés, Department of Medicine, Santa Cruz de la Sierra, Bolivia. 31Department of Cardiology, Instituto de Cardiología y Cirugía Cardiovascular, La Habana, Cuba. 32Department of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 33Department of Cardiology, Hospital San Vicente de Paul, Heredia, Costa Rica. 34Department of Cardiology, Hospital Santo Tomas, Panama City, Panama. 35Department of Cardiology, Hospital del Salvador, Santiago, Chile. 36Department of Cardiology, Instituto Nacional del Tórax, Santiago, Chile. 37Department of Cardiology, Hospital Clínica Bíblica, San Jose, Costa Rica.

metadata.articulos.dc.description.uri:

Editorial:

John Wiley & Sons

EN:

Clinical Cardiology. 2024;47(2)

Financiadores:

Citación:

Gómez-Mesa J, Gutiérrez-Posso J, Escalante-Forero M y otros. American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patients. Clinical Cardiology [en línea]. 2024;47(2). 9 p.

Citación:

metadata.articulos.cc.license.name:

ISBN:

e-ISBN:

ISSN:

ISMN:

Otros identificadores:

Cobertura geográfica:

ESTADOS UNIDOS

Cobertura temporal:

Departamento académico:

Grupo de investigación:

Licencia:

Licencia Creative Commons Atribución (CC - By 4.0)

Colecciones:

Publicaciones Académicas y Científicas
FicherosDescripciónTamañoFormato
American Registry of Ambulatory or acutely decompensated heart failure.pdf American Registry of Ambulatory or acutely decompensated heart failure 14.86 MB Adobe PDF
Mostrar el registro Dublin Core completo del ítem